cadmium metallothionein has been researched along with sulfinpyrazone in 1 studies
Studies (cadmium metallothionein) | Trials (cadmium metallothionein) | Recent Studies (post-2010) (cadmium metallothionein) | Studies (sulfinpyrazone) | Trials (sulfinpyrazone) | Recent Studies (post-2010) (sulfinpyrazone) |
---|---|---|---|---|---|
303 | 0 | 27 | 1,122 | 172 | 32 |
Protein | Taxonomy | cadmium metallothionein (IC50) | sulfinpyrazone (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 14.4 | |
fMet-Leu-Phe receptor | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gale, GR; Jones, MM; Singh, PK; Smith, AB; Tasende, MS | 1 |
1 other study(ies) available for cadmium metallothionein and sulfinpyrazone
Article | Year |
---|---|
Monoisoamyl meso-2,3-dimercaptosuccinate: interaction with metallothionein-bound cadmium in vitro and evidence of active transport into renal and hepatic cells in vivo.
Topics: Animals; Biological Transport, Active; Cadmium; Kidney; Liver; Male; Metallothionein; Mice; Probenecid; Succinates; Sulfinpyrazone; Thiocarbamates | 1992 |